Differential translation and fragile X syndrome
- PMID: 16098135
- DOI: 10.1111/j.1601-183X.2005.00134.x
Differential translation and fragile X syndrome
Abstract
Fragile X syndrome (FXS) is caused by the transcriptional silencing of the Fmr1 gene, which encodes a protein (FMRP) that can act as a translational suppressor in dendrites, and is characterized by a preponderance of abnormally long, thin and tortuous dendritic spines. According to a current theory of FXS, the loss of FMRP expression leads to an exaggeration of translation responses linked to group I metabotropic glutamate receptors. Such responses are involved in the consolidation of a form of long-term depression that is enhanced in Fmr1 knockout mice and in the elongation of dendritic spines, resembling synaptic phenotypes over-represented in fragile X brain. These observations place fragile X research at the heart of a long-standing issue in neuroscience. The consolidation of memory, and several distinct forms of synaptic plasticity considered to be substrates of memory, requires mRNA translation and is associated with changes in spine morphology. A recent convergence of research on FXS and on the involvement of translation in various forms of synaptic plasticity has been very informative on this issue and on mechanisms underlying FXS. Evidence suggests a general relationship in which the receptors that induce distinct forms of efficacy change differentially regulate translation to produce unique spine shapes involved in their consolidation. We discuss several potential mechanisms for differential translation and the notion that FXS represents an exaggeration of one 'channel' in a set of translation-dependent consolidation responses.
Similar articles
-
Early postnatal plasticity in neocortex of Fmr1 knockout mice.J Neurophysiol. 2006 Oct;96(4):1734-45. doi: 10.1152/jn.00221.2006. Epub 2006 Jul 5. J Neurophysiol. 2006. PMID: 16823030
-
mRNPs, polysomes or granules: FMRP in neuronal protein synthesis.Curr Opin Neurobiol. 2006 Jun;16(3):265-9. doi: 10.1016/j.conb.2006.05.010. Epub 2006 May 16. Curr Opin Neurobiol. 2006. PMID: 16707258 Review.
-
The fragile X syndrome: from molecular genetics to neurobiology.Ment Retard Dev Disabil Res Rev. 2004;10(1):60-7. doi: 10.1002/mrdd.20010. Ment Retard Dev Disabil Res Rev. 2004. PMID: 14994290 Review.
-
Altered synaptic plasticity in a mouse model of fragile X mental retardation.Proc Natl Acad Sci U S A. 2002 May 28;99(11):7746-50. doi: 10.1073/pnas.122205699. Proc Natl Acad Sci U S A. 2002. PMID: 12032354 Free PMC article.
-
Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency.Mol Cell Neurosci. 2002 Feb;19(2):138-51. doi: 10.1006/mcne.2001.1085. Mol Cell Neurosci. 2002. PMID: 11860268
Cited by
-
Visual Behavior Impairments as an Aberrant Sensory Processing in the Mouse Model of Fragile X Syndrome.Front Behav Neurosci. 2019 Oct 2;13:228. doi: 10.3389/fnbeh.2019.00228. eCollection 2019. Front Behav Neurosci. 2019. PMID: 31680892 Free PMC article.
-
Morphoregulatory functions of the RNA-binding motif protein 3 in cell spreading, polarity and migration.Sci Rep. 2018 May 9;8(1):7367. doi: 10.1038/s41598-018-25668-2. Sci Rep. 2018. PMID: 29743635 Free PMC article.
-
De Novo Missense Mutations in DHX30 Impair Global Translation and Cause a Neurodevelopmental Disorder.Am J Hum Genet. 2017 Nov 2;101(5):716-724. doi: 10.1016/j.ajhg.2017.09.014. Am J Hum Genet. 2017. PMID: 29100085 Free PMC article.
-
Monitoring mRNA Translation in Neuronal Processes Using Fluorescent Non-Canonical Amino Acid Tagging.J Histochem Cytochem. 2016 May;64(5):323-33. doi: 10.1369/0022155416641604. Epub 2016 Mar 29. J Histochem Cytochem. 2016. PMID: 27026294 Free PMC article.
-
microRNAs as Biomarker in Depression Pathogenesis.Ann Psychiatry Ment Health. 2013;1(1):1003. Epub 2013 Dec 2. Ann Psychiatry Ment Health. 2013. PMID: 26894231 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical